Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 70756-704

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 70756-704). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lifestar Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4ec581cf B92f 480e 8814 72756efc9f0a 01

Chemical structure of ranolazine, showing its molecular arrangement including aromatic rings, an amide group, an ether linkage, and a methoxy-substituted phenyl ring, consistent with the active ingredient ranolazine.*

FDA Label Image

4ec581cf B92f 480e 8814 72756efc9f0a 02

Label for Ranolazine Extended-Release Tablets, 500 mg, in a package of 60 tablets. The label states the product is manufactured for Lifestar Pharma LLC and made in India. It includes storage instructions and warnings to keep out of reach of children, with directions to swallow tablets whole without crushing, breaking, or chewing.*

FDA Label Image

4ec581cf B92f 480e 8814 72756efc9f0a 03

Label for Ranolazine Extended-Release Tablets, 1000 mg strength, film-coated oral tablets. The package contains 60 tablets and is labeled for prescription use only. Manufactured by Lifestar Pharma LLC, located in Mahwah, New Jersey, with the product made in India. Instructions note to swallow tablets whole without crushing, breaking, or chewing, and to store at controlled room temperature (20°C to 25°C).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.